Windward Bio has launched the Phase II POLARIS trial of the recombinant, fully human monoclonal antibody, WIN378, in individuals with asthma.

BASEL, Switzerland, July 23, 2025 (GLOBE NEWSWIRE) -- Windward Bio AG, a private, clinical-stage biotechnology company committed to improving outcomes for people living with advanced immunological ...

U pstream Bio has dosed the first subject in the randomised Phase II trial of verekitug, an antibody antagonist targeting the thymic stromal lymphopoietin (TSLP) receptor, in individuals with chronic ...

In the segment, while products like Nucala and Dovato are key top-line drivers, new long-acting HIV medicines, Cabenuva and Apretude, as well as new oncology drugs Jemperli and Ojjaara, are also ...

Head-to-Head Trial Finds Winner for CRSwNP With Asthma Dupilumab improved nasal polyp outcomes and asthma symptoms more than omalizumab in patients with CRSwNP and asthma, according to the head-to ...

Topics covered include rising food allergies in children, the psychological burden of chronic allergic diseases, predictors ...

Dupilumab in patients with diffuse type 2 CRSwNP had beneficial changes in nasal passage microbiota but did not alter gastrointestinal microbiota.

The UK’s pioneering licensed IVF technique to reduce the risk of mitochondrial diseases carried out in Newcastle, UK, has seen eight babies born, published research shows. All eight babies ...

A new study investigates the link between processed meat, sugar-sweetened beverages, and trans fatty acids, to diseases such as cancer, heart disease and type 2 diabetes.

Study analyzing 77 research papers finds habitual consumption of processed foods increases chronic disease risk, challenging assumptions about safe levels.

Can you diet actually treat chronic disease? The research and science on when “food is medicine”—and when it isn’t—for cancer, heart disease, type 2 diabetes.